Autoimmune bullous diseases: Ocular manifestations and management

Keyphrases

• Ocular Manifestations 100%
• Autoimmune Bullous Disease 100%
• Recent Advances 50%
• Inflammation 50%
• Monoclonal Antibody 50%
• Early Detection 50%
• Pathological Process 50%
• Difficult-to-treat 50%
• Systemic Therapy 50%
• Advanced Disease 50%
• Surgical Intervention 50%
• Ocular Diseases 50%
• Pemphigus Vulgaris 50%
• Ophthalmic Diseases 50%
• Immunomodulator 50%
• Paraneoplastic Pemphigus 50%
• Ocular Involvement 50%
• Visual Loss 50%
• Mycophenolate Mofetil 50%
• Sight-threatening 50%
• Topical Tacrolimus 50%
• Conjunctival Inflammation 50%
• Cicatricial Pemphigoid 50%
• Epidermolysis Bullosa Acquisita 50%
• Corneal Pathology 50%
• Mucous Membrane Pemphigoid 50%
• Irreversible Blindness 50%
• Linear IgA Bullous Disease 50%
• Ophthalmic Involvement 50%

Medicine and Dentistry

• Bullous Disease 100%
• Agents Acting on the Eye 66%
• Cicatricial Pemphigoid 66%
• Diseases 66%
• Monoclonal Antibody 33%
• Physical Disease by Body Function 33%
• Immunoglobulin A 33%
• Eye Disease 33%
• Visual Impairment 33%
• Systemic Therapy 33%
• Pathological Process 33%
• Immunomodulating Agent 33%
• Tacrolimus 33%
• Paraneoplastic Pemphigus 33%
• Pemphigus vulgaris 33%
• Lid 33%
• Epidermolysis Bullosa Acquisita 33%
• Corneal Pathology 33%
• Mycophenolate Mofetil 33%